Avg closing price
Price range

4 Joel Greenblatt Theravance Biopharma Trades

The first Theravance Biopharma trade was made in Q4 2015. Since then Joel Greenblatt bought shares one more times and sold shares on two occasions. The investor sold all their shares in Q1 2017 and doesn't own any shares in Theravance Biopharma anymore.

Avg closing price
Price range
Sold -9.57 Thousand shares Q1 2017
Avg closing price $31.95
Price range $28.28 - $37.06
New holding (+9.57 Thousand shares) Q4 2016
Avg closing price $31.02
Price range $24.57 - $38.58
Sold -69.6 Thousand shares Q1 2016
Avg closing price $16.36
Price range $13.35 - $18.80
New holding (+69.6 Thousand shares) Q4 2015
Avg closing price $15.87
Price range $11.13 - $19.51

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!